Cookie Policy

Always read the label. Follow the directions for use. If symptoms persist, talk to your healthcare professional.

1. Rowbotham MC et al. Pain 1996;65(1):39–44. 2. Katz NP et al. Pain Med 2002;3(4):324 –32. (Funded by Endo Pharmaceuticals) 3. Sabatowski R et al. Curr Med Res Opin 2012; 28(8):1337–46. Results achieved in a 3-year extension trial assessing pain relief in patients with PHN using Nervoderm (up to 3 patches). Funded by Grünenthal GmbH.4. Nervoderm® Approved Consumer Medicine Information July 2016. 5. Rehm S et al Curr Med Res & Opin 2010;26(7):1607-1619
Nervoderm© is a registered trademark of Seqirus™ UK Ltd or its affiliates. Seqirus™ (Australia) Pty Ltd ABN 66 120 398 067, Tower 1, Level 12 Collins Square, 727 Collins Street, Melbourne 3000. Medical information: 1800 642 865. Date of preparation: December 23. AU-NVD-23-0013. SEQ-002510-00.

©2021 Nervoderm. All rights reserved.
Privacy Policy Cookie Policy